Pharmacy Use and Costs in Employer-Provided Health Plans
Insights for TRICARE Benefit Design from the Private Sector
ResearchPublished Feb 8, 2005
The military health system, as well as the private health care sector, has experienced rapid growth in pharmaceutical expenditures. In 2002 alone, the Department of Defense spent about $3 billion on outpatient pharmacy benefits. As part of an effort to redesign the TRICARE pharmacy benefit to save costs, the Department of Defense is considering moving from a two-tiered to a three-tiered co-payment system, which will increase the co-payment for some classes and brands of drugs. Providers (acting in the interest of their patients) would, theoretically, have an incentive to prescribe less-costly options. To predict how changing to a three-tiered system will affect costs and pharmacy utilization, the authors use an existing data resource to determine how beneficiaries age 45 to 64 in private-sector health plans responded to similar changes in pharmacy benefits. In this analysis, the authors assess, among other potential outcomes, how changing to a three-tiered system would affect aggregate costs and pharmacy utilization and how it would affect the utilization of specific (high-cost) classes of medications.
Related Content
Topics
Document Details
- Copyright: RAND Corporation
- Availability: Available
- Year: 2005
- Print Format: Paperback
- Paperback Pages: 104
- Paperback Price: $20.00
- Paperback ISBN/EAN: 978-0-8330-3549-3
- Document Number: MG-154-OSD
Citation
RAND Style Manual
Chicago Manual of Style
Joyce, Geoffrey F., Jesse D. Malkin, and Jennifer E. Pace, Pharmacy Use and Costs in Employer-Provided Health Plans: Insights for TRICARE Benefit Design from the Private Sector, RAND Corporation, MG-154-OSD, 2005. As of September 9, 2024: https://www.rand.org/pubs/monographs/MG154.html
Joyce, Geoffrey F., Jesse D. Malkin, and Jennifer E. Pace, Pharmacy Use and Costs in Employer-Provided Health Plans: Insights for TRICARE Benefit Design from the Private Sector. Santa Monica, CA: RAND Corporation, 2005. https://www.rand.org/pubs/monographs/MG154.html. Also available in print form.
Research conducted by
The research described in this report was sponsored by the Office of the Secretary of Defense (OSD). The research was conducted jointly by the Center for Military Health Policy Research, a RAND Health program, and the Forces and Resources Policy Center, a RAND National Defense Research Institute (NDRI) program. NDRI is a federally funded research and development center supported by the OSD, the Joint Staff, the unified commands, and the defense agencies.
This publication is part of the RAND monograph series. RAND monographs were products of RAND from 2003 to 2011 that presented major research findings that addressed the challenges facing the public and private sectors. All RAND monographs were subjected to rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.